[{"NetIncomeLoss_1_Q1_USD":-135680000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":28350000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":50779364.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":9456000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-455528000.0,"Depreciation_1_Q1_USD":294000.0,"PaymentsToAcquireInvestments_1_Q1_USD":621661000.0,"AccruedLiabilitiesCurrentAndNoncurrent_0_Q1_USD":57503000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":204000.0,"AssetsCurrent_0_Q1_USD":1303510000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":10801419.0,"CommonStockSharesIssued_0_Q1_shares":51375786.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":957660000.0,"Assets_0_Q1_USD":1380832000.0,"UnrealizedGainLossOnInvestments_1_Q1_USD":-3953000.0,"ShareBasedCompensation_1_Q1_USD":24722000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":39278000.0,"MarketableSecuritiesCurrent_0_Q1_USD":957660000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":9885000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":104071000.0,"PrepaidExpenseCurrent_0_Q1_USD":9933000.0,"AssetsFairValueDisclosure_0_Q1_USD":1298839000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-3259000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_1_Q1_USD":-1001000.0,"CommonStockValue_0_Q1_USD":51000.0,"Revenues_1_Q1_USD":0.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":4371000.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":2810000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":9885000.0,"RestrictedCash_0_Q1_USD":620000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-135983000.0,"OtherAssetsNoncurrent_0_Q1_USD":17307000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":329503000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":43175000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_1_Q1_USD":167240000.0,"Liabilities_0_Q1_USD":121419000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-303000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":8149000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":0.0,"InterestReceivableCurrent_0_Q1_USD":1838000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":140000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":24722000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-110416000.0,"StockIssuedDuringPeriodValueEmployeeBenefitPlan_1_Q1_USD":9885000.0,"LiabilitiesCurrent_0_Q1_USD":77105000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":330123000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":16347000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":9900000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":329503000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":5143000.0,"AccountsPayableCurrentAndNoncurrent_0_Q1_USD":19602000.0,"AdditionalPaidInCapital_0_Q1_USD":2515824000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":312903.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":439000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":9061000.0,"InvestmentsFairValueDisclosure_0_Q1_USD":957660000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"RestrictedCashNoncurrent_0_Q1_USD":600000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-556059000.0,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"OperatingIncomeLoss_1_Q1_USD":-132421000.0,"PreferredStockValue_0_Q1_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":1380832000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":7689000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":24722000.0,"OperatingExpenses_1_Q1_USD":132421000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-2.67,"OtherLiabilitiesNoncurrent_0_Q1_USD":1139000.0,"StockholdersEquity_0_Q1_USD":1259413000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q1_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":1107000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":957724000.0,"LongTermInvestments_0_Q1_USD":11676000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1265918000.0,"CommonStockSharesOutstanding_0_Q1_shares":51375786.0,"ClassOfWarrantOrRightOutstanding_0_Q1_shares":7605811.0,"Ticker":"MRTX","CIK":"1576263","name":"MIRATI THERAPEUTICS, INC.","OfficialName":"Mirati Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"4261498445.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]